|
2025 Journal Article Low rates of surgical recurrence following ileocolic resections for Crohn’s disease in the biologic eraGiddings, Hugh L., Ng, Kheng-Seong, Solomon, Michael J., Arzivian, Arteen, Haifer, Craig, Lin, Huiyu, Pappas, Christian, Clark, David, Deacon, Anthony, Radford-Smith, Graham, Ebrahimi, Nargus, Wu, Ann, Lewis, Mark, Lim, Roscoe, Zhang, Jennifer, Vasudevan, Abhinav, Demase, Kathryn, Karp, Jadon, Fernandes, Richard G., An, Yoon-Kyo, Ng, Zi Qin, Mackenzie, Scott, Thin, Lena, Greeve, Tessa, Moore, Gregory T., Connor, Susan J., Andrews, Jane M., Sparrow, Miles P., Ghaly, Simon and Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC), Crohn’s Colitis Cure (CCCure), Post Operative Recurrence and Surgical Outcomes following Crohn’s Ileocolic Resections in Australia study (PORSCIA study collaborative) (2025). Low rates of surgical recurrence following ileocolic resections for Crohn’s disease in the biologic era. Inflammatory Bowel Diseases izaf244. doi: 10.1093/ibd/izaf244 |
|
2025 Journal Article Point-of-care intestinal ultrasound impacts inflammatory bowel disease care and reduces the need for additional investigationsTan, Wei-Lian, Khoo, Emi, Khaing, Myat-Myat, Barr, Emily, Fernandes, Richard G., Pham, Hai, An, Yoon-Kyo and Begun, Jakob (2025). Point-of-care intestinal ultrasound impacts inflammatory bowel disease care and reduces the need for additional investigations. Journal of Gastroenterology and Hepatology, 40 (10), 2472-2481. doi: 10.1111/jgh.70019 |
|
2025 Journal Article Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyGilmore, Robert, Fernandes, Richard, Hartley, Imogen, Arzivian, Arteen, Leong, Rupert, Andrew, Bridgette, Vasudevan, Abhinav, Greeve, Tessa, Moore, Gregory Thomas, Kim, Steven, Lightowler, Daniel, Singh, Abhey, Mahy, Gillian, Mithanthaya, Aditya, Venugopaul, Kannan, Han, Sangwoo, Bryant, Robert, West, Jack, Segal, Jonathan, Christensen, Britt, Corte, Crispin, Ding, Nik, An, Yoon-Kyo and Begun, Jakob (2025). Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study. Intestinal Research, 23 (3), 347-357. doi: 10.5217/ir.2024.00127 |
|
2025 Journal Article The durability of anti-TNF therapy for Crohn’s Disease is higher in anti-TNF naïve patients and increases with proactive therapeutic drug monitoringGilmore, Robert, Fernandes, Richard, Schildkraut, Tamar, Joshi, Riddhi, Lin, Lyman, Vorgin, Sara, Etchegaray, Amirah, Shanmuga Anandan, Aathavan, Tambakis, George, Loebenstein, Moshe, An, Yoon-Kyo, Begun, Jakob and Wright, Emily K (2025). The durability of anti-TNF therapy for Crohn’s Disease is higher in anti-TNF naïve patients and increases with proactive therapeutic drug monitoring. Crohn's and Colitis 360, 7 (2) otaf028, 1-9. doi: 10.1093/crocol/otaf028 |
|
2025 Journal Article Comparing long‐term infliximab persistence following a switch to a biosimilar in patients with inflammatory bowel disease: no cause for concernSuo, Paulina, Srinivasan, Ashish, Thin, Lena, An, Yoon‐Kyo, Fernandes, Richard G., Ghaly, Simon, Jeffrey, Angus W., Menon, Shankar, Olsen, Nicholas, Skinner, Thomas, van Langenberg, Daniel R., Winston, James and Haifer, Craig (2025). Comparing long‐term infliximab persistence following a switch to a biosimilar in patients with inflammatory bowel disease: no cause for concern. Journal of Gastroenterology and Hepatology, 40 (5), 1174-1181. doi: 10.1111/jgh.16916 |
|
2025 Journal Article Upadacitinib was administered as a sequential salvage therapy for acute severe ulcerative colitis: a case reportHuynh, David, Khaing, Myat Myat, Fernandes, Richard Gareth, Malloy, Reuben, Lin, Lei, Gilmore, Robert, Walker, Nicole, Khoo, Emi and Begun, Jakob (2025). Upadacitinib was administered as a sequential salvage therapy for acute severe ulcerative colitis: a case report. Case Reports in Gastroenterology, 19 (1), 1-6. doi: 10.1159/000542711 |
|
2023 Journal Article Upadacitinib salvage therapy for infliximab experienced patients with acute severe ulcerative colitisGilmore, Robert, Tan, Lian, Fernandes, Richard, An, Yoon-Kyo and Begun, Jakob (2023). Upadacitinib salvage therapy for infliximab experienced patients with acute severe ulcerative colitis. Journal of Crohn's and Colitis, 17 (12), 2033-2036. doi: 10.1093/ecco-jcc/jjad115 |
|
2022 Journal Article Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosisMalloy, Reuben, Fernandes, Richard, Begun, Jakob and An, Yoon-Kyo (2022). Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis. BMJ Case Reports, 15 (12) 252140, e252140. doi: 10.1136/bcr-2022-252140 |
|
2022 Journal Article Editorial: is older-onset ulcerative colitis more severe or less aggressively managed?Fernandes, Richard G. and Radford-Smith, Graham (2022). Editorial: is older-onset ulcerative colitis more severe or less aggressively managed?. Alimentary Pharmacology & Therapeutics, 55 (10), 1350-1351. doi: 10.1111/apt.16905 |
